Search research articles
Contact Us
Filters
Showing results (81-90 of 359) with videos related to
Page
of 36
Sort By:
Journal of Medicinal Chemistry
|
July 11, 2006
Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide
Thomas Clifford, C Andrew Boswell, Grainne B Biddlecombe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 3, 2018
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2
Sophie Poty, Lynn C Francesconi, Michael R McDevitt, et al.
Chemistryopen
|
May 9, 2014
Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis
Brian M Zeglis, Fabien Emmetiere, Nagavarakishore Pillarsetty, et al.
Nuclear Medicine and Biology
|
January 21, 2014
Influence of free fatty acids on glucose uptake in prostate cancer cells
Kim Francis Andersen, Vadim Divilov, Kuntalkumar Sevak, et al.
Bioconjugate Chemistry
|
September 22, 2023
Click Chemistry and Radiochemistry: An Update
David Bauer, Mike A Cornejo, Tran T Hoang, et al.
Inorganic Chemistry
|
December 10, 2013
Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals
Brian M Zeglis, Jacob L Houghton, Michael J Evans, et al.
Inorganic Chemistry
|
August 18, 2020
A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89
Elaheh Khozeimeh Sarbisheh, Akam K Salih, Shvan J Raheem, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
Exploring the PET in vivo generator <sup>134</sup>Ce as a theranostic match for <sup>225</sup>Ac
David Bauer, Roberto De Gregorio, Edwin C Pratt, et al.
Trends in Biotechnology
|
April 26, 2017
Applications of pHLIP Technology for Cancer Imaging and Therapy
Linden C Wyatt, Jason S Lewis, Oleg A Andreev, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2026
Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer
Angelique Loor, Kyeara N Mack, David Bauer, et al.
Page
of 36
Search research articles
Search
Showing results (81-90 of 359) with videos related to
Sort By:
Page
of 36
Journal of Medicinal Chemistry
|
July 11, 2006
Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide
Thomas Clifford, C Andrew Boswell, Grainne B Biddlecombe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 3, 2018
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2
Sophie Poty, Lynn C Francesconi, Michael R McDevitt, et al.
Chemistryopen
|
May 9, 2014
Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis
Brian M Zeglis, Fabien Emmetiere, Nagavarakishore Pillarsetty, et al.
Nuclear Medicine and Biology
|
January 21, 2014
Influence of free fatty acids on glucose uptake in prostate cancer cells
Kim Francis Andersen, Vadim Divilov, Kuntalkumar Sevak, et al.
Bioconjugate Chemistry
|
September 22, 2023
Click Chemistry and Radiochemistry: An Update
David Bauer, Mike A Cornejo, Tran T Hoang, et al.
Inorganic Chemistry
|
December 10, 2013
Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals
Brian M Zeglis, Jacob L Houghton, Michael J Evans, et al.
Inorganic Chemistry
|
August 18, 2020
A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89
Elaheh Khozeimeh Sarbisheh, Akam K Salih, Shvan J Raheem, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
Exploring the PET in vivo generator <sup>134</sup>Ce as a theranostic match for <sup>225</sup>Ac
David Bauer, Roberto De Gregorio, Edwin C Pratt, et al.
Trends in Biotechnology
|
April 26, 2017
Applications of pHLIP Technology for Cancer Imaging and Therapy
Linden C Wyatt, Jason S Lewis, Oleg A Andreev, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2026
Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer
Angelique Loor, Kyeara N Mack, David Bauer, et al.
Page
of 36